January 6, 2017 10:34 AM EST
News Briefing

Genen­tech vet Troy Cox named Foun­da­tion Med CEO; Mo­men­ta inks a $600M col­lab­o­ra­tion deal

Shehla Shakoor

Managing Director

• Troy Cox, the se­nior VP of on­col­o­gy sales and mar­ket­ing at Genen­tech, is leav­ing the big Roche sub­sidiary to take the CEO’s job …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times